These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3033999)

  • 21. [ACE inhibitors and vagal activity: the effect of captopril and lisinopril on cardiovascular reflexes].
    Quadri R; Papotti GM; La Grotta A; Maule S; Zanone M; Valentini M; Fonzo D; Chiandussi L
    Ann Ital Med Int; 1992; 7(3):148-52. PubMed ID: 1333780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
    Sun Y; Mendelsohn FA
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):478-86. PubMed ID: 1724523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in structure of angiotensin-converting enzyme inhibitors might predict differences in action.
    Herman AG
    Am J Cardiol; 1992 Oct; 70(10):102C-108C. PubMed ID: 1329464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
    Perich RB; Jackson B; Johnston CI
    Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat.
    Hubner RA; Kubota E; Casley DJ; Johnston CI; Burrell LM
    J Hypertens; 2001 May; 19(5):941-6. PubMed ID: 11393678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.
    Lieberman J; Zakria F
    Sarcoidosis; 1989 Sep; 6(2):118-23. PubMed ID: 2557660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo determinations of Ki values for angiotensin converting enzyme inhibitors.
    Catravas JD; Anthony BL
    Adv Exp Med Biol; 1986; 198 Pt A():453-9. PubMed ID: 3028064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding.
    Jackson B; Cubela R; Johnston CI
    Aust J Exp Biol Med Sci; 1986 Apr; 64 ( Pt 2)():149-55. PubMed ID: 3017276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography--mass spectrometry and its application to pharmacokinetic studies.
    Franklin ME; Addison RS; Baker PV; Hooper WD
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):47-54. PubMed ID: 9498669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    Cardiovasc Res; 1993 Feb; 27(2):312-7. PubMed ID: 8386065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes.
    Petrov V; Fagard R; Lijnen P
    Am J Hypertens; 2000 May; 13(5 Pt 1):535-9. PubMed ID: 10826406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis.
    Walsh DA; Catravas J; Wharton J
    Ann Rheum Dis; 2000 Feb; 59(2):125-31. PubMed ID: 10666168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
    Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of angiotensin-converting enzyme in canine testis.
    Sabeur K; Vo AT; Ball BA
    Reproduction; 2001 Jul; 122(1):139-46. PubMed ID: 11425338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor binding.
    Jackson B; Cubela R; Sakaguchi K; Johnston CI
    Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):343-7. PubMed ID: 2822313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.